Overview Trandolapril 4 mg Tablet Under Fasting Conditions Status: Completed Trial end date: 2004-11-01 Target enrollment: Participant gender: Summary The objective of this study is to compare the rate and extent of absorption of trandolapril from a test formulation of Trandolapril 4 mg Tablets versus the reference Mavik® 4 mg Tablets under fasting conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: Trandolapril